Patents Assigned to PHARMACYL AB
  • SUBSTITUTED BENZAMIDES AND THEIR USE IN THERAPY
    Publication number: 20250064761
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, and a pharmaceutical composition comprising the compound. The compound is useful for the treatment a disease resulting from pathologic inflammation, such as inflammatory bowel disease, psoriasis or rheumatoid arthritis.
    Type: Application
    Filed: April 9, 2024
    Publication date: February 27, 2025
    Applicant: PHARMACYL AB
    Inventors: Anders BJÖRK, Gunnar HEDLUND
  • Medical treatment for pathologic inflammation
    Patent number: 11896564
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, for use in combination with a 5-ASA agent, in the treatment of a disease resulting from pathologic inflammation. The combination of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof and 5-ASA agent and use of such combination. A kit-of-parts and a pharmaceutical composition comprising such a combination.
    Type: Grant
    Filed: August 15, 2019
    Date of Patent: February 13, 2024
    Assignee: PHARMACYL AB
    Inventors: Gunnar Hedlund, Anders Björk
  • Treatment of spondyloarthritis
    Patent number: 11717500
    Abstract: A method for the treatment a disease resulting from spondyloarthritis, such as axial spondyloarthritis, psoriatic arthritis and enteropathic arthritis, by administering, to a mammal in need of such treatment, a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: January 26, 2021
    Date of Patent: August 8, 2023
    Assignee: PHARMACYL AB
    Inventors: Anders Björk, Gunnar Hedlund